
URGN CLASS ACTION NOTICE: UroGen Pharma Ltd. has been Sued for Securities Fraud after Stock Plummets 45% – Contact BFA ...
NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ: URGN) and certain of the Company’s senior executives for potential violations …